| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10697 | 2021 |
| Cyclooxygenase‐independent actions of cyclooxygenase inhibitors I Tegeder, J Pfeilschifter, G Geisslinger The FASEB Journal 15 (12), 2057-2072, 2001 | 929 | 2001 |
| COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxib S Grösch, I Tegeder, E Niederberger, L Bräutigam, G Geisslinger The FASEB journal 15 (14), 1-22, 2001 | 691 | 2001 |
| GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence I Tegeder, M Costigan, RS Griffin, A Abele, I Belfer, H Schmidt, C Ehnert, ... Nature medicine 12 (11), 1269-1277, 2006 | 649 | 2006 |
| Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors N Agarwal, P Pacher, I Tegeder, F Amaya, CE Constantin, GJ Brenner, ... Nature neuroscience 10 (7), 870-879, 2007 | 640 | 2007 |
| Pharmacokinetics of opioids in liver disease I Tegeder, J Lötsch, G Geisslinger Clinical pharmacokinetics 37, 17-40, 1999 | 369 | 1999 |
| Opioids as modulators of cell death and survival—unraveling mechanisms and revealing new indications I Tegeder, G Geisslinger Pharmacological reviews 56 (3), 351-369, 2004 | 265 | 2004 |
| Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting H Dormann, U Muth-Selbach, S Krebs, M Criegee-Rieck, I Tegeder, ... Drug safety 22, 161-168, 2000 | 246 | 2000 |
| No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing A Schmidtko, I Tegeder, G Geisslinger Trends in neurosciences 32 (6), 339-346, 2009 | 236 | 2009 |
| G Protein-independent G1 Cell Cycle Block and Apoptosis with Morphine in Adenocarcinoma Cells: Involvement of p53 Phosphorylation I Tegeder, S Grösch, A Schmidtko, A Häussler, H Schmidt, ... Cancer research 63 (8), 1846-1852, 2003 | 200 | 2003 |
| Specific inhibition of IκB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats I Tegeder, E Niederberger, R Schmidt, S Kunz, H Gühring, O Ritzeler, ... Journal of Neuroscience 24 (7), 1637-1645, 2004 | 192 | 2004 |
| Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB E Niederberger, I Tegeder, G Vetter, A Schmidtko, H Schmidt, ... The FASEB Journal 15 (9), 1622-1624, 2001 | 191 | 2001 |
| Acetaminophen Inhibits Spinal Prostaglandin E2Release after Peripheral Noxious Stimulation US Muth-Selbach, I Tegeder, K Brune, G Geisslinger The Journal of the American Society of Anesthesiologists 91 (1), 231-239, 1999 | 180 | 1999 |
| Peripheral opioid analgesia in experimental human pain models I Tegeder, S Meier, M Burian, H Schmidt, G Geisslinger, JÈ LoÈtsch Brain 126 (5), 1092-1102, 2003 | 175 | 2003 |
| Reduction of neuropathic and inflammatory pain through inhibition of the tetrahydrobiopterin pathway A Latremoliere, A Latini, N Andrews, SJ Cronin, M Fujita, K Gorska, ... Neuron 86 (6), 1393-1406, 2015 | 152 | 2015 |
| Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol MV Tzvetkov, AR Saadatmand, J Lötsch, I Tegeder, JC Stingl, ... Clinical Pharmacology & Therapeutics 90 (1), 143-150, 2011 | 150 | 2011 |
| Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation G Vetter, G Geisslinger, I Tegeder Pain 92 (1-2), 213-218, 2001 | 146 | 2001 |
| Release of algesic substances in human experimental muscle pain I Tegeder, J Zimmermann, ST Meller, G Geisslinger Inflammation Research 51, 393-402, 2002 | 139 | 2002 |
| Effects of selective COX‐1 and‐2 inhibition on formalin‐evoked nociceptive behaviour and prostaglandin E2 release in the spinal cord I Tegeder, E Niederberger, G Vetter, L Bräutigam, G Geisslinger Journal of neurochemistry 79 (4), 777-786, 2001 | 139 | 2001 |
| Pathophysiology and treatment of pain in joint disease HG Schaible, M Schmelz, I Tegeder Advanced drug delivery reviews 58 (2), 323-342, 2006 | 138 | 2006 |
